Biaryl kinase inhibitors
AssigneeBristol-Myers Squibb Company
InventorsGuanglin Luo, Carolyn Diane Dzierba, John E. Macor
Life of this patent
Estimating the term…
Abstract
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
Claims2
A method for treating or managing a disease or a disorder mediated by AAK1 activity, the method comprising administering to a patient in need thereof a therapeutically effective amount of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine, or a pharmaceutically acceptable salt thereof, and a glucocorticoid, wherein the disease or disorder mediated by AAK1 activity is pain.
Dependencies are inferred from the claim text.